7 TI - Epidemiology of intracerebral hemorrhage.
|
|
|
- Ophelia Dennis
- 5 years ago
- Views:
Transcription
1 1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg Aug;1():-8. Review. IDS - PMID: 1000 UI: TI - Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. AU - Greenberg SM SO - Neurology Sep;51():90-. Review. IDS - PMID: UI: TI - Recurrent primary cerebral hemorrhage: frequency, mechanisms, and prognosis. AU - Gonzalez-Duarte A, et al. SO - Stroke Sep;9(9): Review. IDS - PMID: UI: 9800 TI - Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 0 cases and review of the literature. AU - Zhu XL, et al. SO - Stroke. 199 Jul;8():10-9. Review. IDS - PMID: 99 UI: 91 5 TI - Cerebral amyloid angiopathy. A review. AU - Opeskin K SO - Am J Forensic Med Pathol. 199 Sep;1():8-5. Review. IDS - PMID: 8808 UI: 909 TI - Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. AU - Hart RG, et al. SO - Stroke Aug;(8):11-. Review. IDS - PMID: 15 UI: 9558 TI - Epidemiology of intracerebral hemorrhage.
2 AU - Thrift AG, et al. SO - Epidemiol Rev. 1995;1():1-81. Review. No abstract available. IDS - PMID: 8551 UI: TI - Controversies in the management of spontaneous cerebellar haemorrhage. A consecutive series of 9 cases and review of the literature. AU - van Loon J, et al. SO - Acta Neurochir (Wien). 199;1(-):18-9. Review. IDS - PMID: 80 UI: TI - Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. AU - Chiu D, et al. SO - Stroke Jan;9(1):18-. IDS - PMID: 95 UI: TI - PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. AU - del Zoppo GJ, et al. SO - Stroke Jan;9(1):-11. IDS - PMID: 950 UI: TI - The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. AU - Fujii K, et al. SO - Clin Neurol Neurosurg. 199 Oct;99 Suppl :S19-5. IDS - PMID: 909 UI: TI - Intracerebral hemorrhage after intravenous t-pa therapy for ischemic stroke. The NINDS t-pa Stroke Study Group. SO - Stroke. 199 Nov;8(11): IDS - PMID: UI: TI - Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trials. AU - Murray GD, et al. SO - Acta Neurochir (Wien). 199;18(10):11-.
3 IDS - PMID: 8955 UI: 9115 TI - Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. AU - Akdemir H, et al. SO - Neurosurg Rev. 1995;18(): IDS - PMID: 80 UI: 9009 TI - Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. AU - Ueda T, et al. SO - Stroke. 199 Feb;5():98-0. IDS - PMID: 805 UI: TI - Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tpa) for Occluded Coronary Arteries. AU - Mahaffey KW, et al. SO - Am Heart J Sep;18( Pt 1):9-9. IDS - PMID: 1000 UI: TI - Hemorrhage after an acute ischemic stroke.mast-i Collaborative Group. AU - Motto C, et al. SO - Stroke Apr;0():1-. IDS - PMID: UI: TI - Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. AU - de Bruijn SF, et al. SO - Stroke Mar;0():8-8. IDS - PMID: UI: TI - Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. AU - Morgenstern LB, et al. SO - Neurology Nov;51(5):159-. IDS - PMID: UI: 99019
4 5 TI - Prediction of 0-day mortality among patients with thrombolysis-related intracranial hemorrhage. AU - Sloan MA, et al. SO - Circulation Oct ;98(1):1-8. IDS - PMID: 9091 UI: 988 TI - Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis. MAST-I Collaborative Group. Multicentre Acute Stroke Trial--Italy. AU - Ciccone A, et al. SO - Lancet Sep 1;5(911):880. No abstract available. IDS - PMID: 998 UI: TI - Low molecular weight heparinoid, ORG 101 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 101 in Acute Stroke Treatment (TOAST) Investigators. SO - JAMA Apr -9;9(1):15-. IDS - PMID: UI: 98 8 TI - PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. AU - del Zoppo GJ, et al. SO - Stroke Jan;9(1):-11. IDS - PMID: 950 UI: TI - Intracerebral hemorrhage after intravenous t-pa therapy for ischemic stroke. The NINDS t-pa Stroke Study Group. SO - Stroke. 199 Nov;8(11): IDS - PMID: UI: TI - Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. AU - Larrue V, et al. SO - Stroke. 199 May;8(5):95-0.
5 IDS - PMID: 9158 UI: TI - Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. AU - Donnan GA, et al. SO - JAMA. 199 Sep 5;(1):91-. IDS - PMID: UI: TI - Clinical features and pathogenesis of intracerebral hemorrhage after rt-pa and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. AU - Sloan MA, et al. SO - Neurology Apr;5():9-58. IDS - PMID: 950 UI: TI - Continuous irrigation-drainage of the subdural space for the treatment of chronic subdural haematoma. A prospective clinical trial. AU - Ram Z, et al. SO - Acta Neurochir (Wien). 199;10(1-):0-. IDS - PMID: 8515 UI: TI - Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. AU - Gore JM, et al. SO - Circulation Feb;8():8-59. IDS - PMID: 1899 UI: 9111
Intracerebral Hemorrhage
Review of Primary Intracerebral Hemorrhage Réza Behrouz, DO Assistant Professor of Neurology University of South Florida College of Medicine STROKE 85% ISCHEMIC 15% HEMORRHAGIC HEMORRHAGIC STROKE 1/3 Subarachnoid
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in
ENDOVASCULAR THERAPIES FOR ACUTE STROKE
ENDOVASCULAR THERAPIES FOR ACUTE STROKE Cerebral Arteriogram Cerebral Anatomy Cerebral Anatomy Brain Imaging Acute Ischemic Stroke (AIS) Therapy Main goal is to restore blood flow and improve perfusion
1 TI - Stroke mortality in blacks. Disturbing trends. AU - Gillum RF SO - Stroke Aug;30(8): Review. IDS - PMID: UI:
1 TI - Stroke mortality in blacks. Disturbing trends. AU - Gillum RF SO - Stroke. 1999 Aug;30(8):1711-5. Review. IDS - PMID: 10436126 UI: 99365468 2 TI - Mapping the ischaemic penumbra with PET: implications
Thrombolysis in acute stroke
152 Thrombolysis in acute stroke Cerebrovascular disease has a major impact on people s physical, social and mental well-being, and is a major financial burden on the NHS. In recent times, the management
Cerebrovascular Disease lll. Acute Ischemic Stroke. Use of Intravenous Alteplace in Acute Ischemic Stroke Louis R Caplan MD
Cerebrovascular Disease lll. Acute Ischemic Stroke Use of Intravenous Alteplace in Acute Ischemic Stroke Louis R Caplan MD Thrombolysis was abandoned as a stroke treatment in the 1960s due to an unacceptable
Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective
Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective Cathy Sila MD George M Humphrey II Professor and Vice Chair of Neurology Director, Comprehensive Stroke Center
Evidence-based Diagnosis: A Workshop on Evaluating and Using Medical Tests Small Group 3: Friday, June 10, 11:00 12:30. Problems Without Answers
Evidence-based Diagnosis: A Workshop on Evaluating and Using Medical Tests Small Group 3: Friday, June 10, 11:00 12:30 A B C D E Objectives: RCT Checklist RRR vs. ARR NNT = 1/ARR NNH = 1/ARI NNT Treatment
The management of ICH when to operate when not to?
The management of ICH when to operate when not to? Intracranial Hemorrhage High Incidence o Accounts for 10-15% of all strokes 1,2,5 o 80,000 cases in US; 2 million WW 2,5 o Incidence doubles for African-
9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case
September 19 th, 2013 Scott M Lilly, MD PhD Thrombolytics in 2013: Never Say Never Clinical Case 2 1 Evolution of STEMI Therapy The importance of absolute rest in bed for several days is clear James B
New Frontiers in Intracerebral Hemorrhage
New Frontiers in Intracerebral Hemorrhage Ryan Hakimi, DO, MS Director, Neuro ICU Director, Inpatient Neurology Services Greenville Health System Clinical Associate Professor Department of Medicine (Neurology)
Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study
Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec
Complications of Thrombolysis
Complications of Thrombolysis David H. Jang, M.D. Lewis S. Nelson, M.D. Case Summary: An 88 year-old man with a past medical history of hypertension and paroxysmal atrial fibrillation presented to the
Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
Ischemic stroke is a syndrome of multiple etiologies and
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Gregory W. Albers, MD, Chair; Pierre Amarenco, MD; J. Donald Easton, MD; Ralph L. Sacco, MD; and Philip Teal, MD Abbreviations: ACE ASA and Carotid
Outlook for intracerebral haemorrhage after a MISTIE spell
Outlook for intracerebral haemorrhage after a MISTIE spell David J Werring PhD FRCP Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, National Hospital
From interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
EFFICACY AND SAFETY OF INTRA-ARTERIAL THROMBOLYTIC
Open Access Research Journal Medical and Health Science Journal, MHSJ www.pradec.eu ISSN: 1804-1884 (Print) 1805-5014 (Online) Volume 10, 2012, pp. 2-9 EFFICACY AND SAFETY OF INTRA-ARTERIAL THROMBOLYTIC
The three main subtypes of stroke
Neurology 55 Spontaneous intracerebral haemorrhage in the elderly Spontaneous Intracerebral Haemorrhage (ICH) is defined as bleeding into the brain parenchyma without accompanying trauma. This condition
Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia
Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia Charidimou et al, 2012 Pathogenesis of spontaneous and anticoagulationassociated
An Updated Systematic Review of rt-pa in Acute Ischaemic Stroke
Wardlaw An Updated Systematic Review of rt-pa in Acute Ischaemic Stroke Joanna M Wardlaw COMPETING INTERESTS The author is on the Steering Committees of the Third International Stroke Trial (IST3) and
Index. C Capillary telangiectasia, intracerebral hemorrhage in, 295 Carbon monoxide, formation of, in intracerebral hemorrhage, edema due to,
Neurosurg Clin N Am 13 (2002) 395 399 Index Note: Page numbers of article titles are in boldface type. A Age factors, in intracerebral hemorrhage outcome, 344 Albumin, for intracerebral hemorrhage, 336
Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012
Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model
Acute Stroke Management 2009
Acute Stroke Management 2009 Saving the Brain Conference Royal York Hotel January 24, 2009 Frank L. Silver, MD, FRCPC Director, Toronto West Stroke Program Professor of Medicine (Neurology) University
An intravenous thrombolysis using recombinant tissue
ORIGINAL RESEARCH I. Ikushima H. Ohta T. Hirai K. Yokogami D. Miyahara N. Maeda Y. Yamashita Balloon Catheter Disruption of Middle Cerebral Artery Thrombus in Conjunction with Thrombolysis for the Treatment
Since the National Institute of Neurologic Disorders and
ORIGINAL RESEARCH R.M. Sugg E.A. Noser H.M. Shaltoni N.R. Gonzales M.S. Campbell R. Weir E.D. Cacayorin J.C. Grotta Intra-Arterial Reteplase Compared to Urokinase for Thrombolytic Recanalization in Acute
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
Prediction of Hemorrhage in Acute Ischemic Stroke Using Permeability MR Imaging
AJNR Am J Neuroradiol 26:2213 2217, October 2005 Technical Note Prediction of Hemorrhage in Acute Ischemic Stroke Using Permeability MR Imaging Andrea Kassner, Timothy Roberts, Keri Taylor, Frank Silver,
Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!
Thrombolytic therapy should be the first line treatment in acute ishchemic stroke We are against it!! 85% of strokes are ischaemic, and related to blockage of an artery by a blood clot, so potential treatments
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning
PARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET
PARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET Hye Seon Jeong, *Jei Kim Department of Neurology and
Intra-arterial thrombolysis (IAT) has the potential to rescue
Published September 3, 2008 as 10.3174/ajnr.A1276 ORIGINAL RESEARCH G.A. Christoforidis C. Karakasis Y. Mohammad L.P. Caragine M. Yang A.P. Slivka Predictors of Hemorrhage Following Intra-Arterial Thrombolysis
Ischemic stroke is a syndrome of multiple etiologies and
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Gregory W. Albers, MD, Chair; Pierre Amarenco, MD; J. Donald Easton, MD;
Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital
Stroke Management Dr Ben Turner Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Introduction Stroke is the major cause of disability in the developed
Decreased Perihematomal Edema in Thrombolysis-Related Intracerebral Hemorrhage Compared With Spontaneous Intracerebral Hemorrhage
Decreased Perihematomal Edema in Thrombolysis-Related Intracerebral Hemorrhage Compared With Spontaneous Intracerebral Hemorrhage James M. Gebel, MD; Thomas G. Brott, MD; Cathy A. Sila, MD; Thomas A. Tomsick,
Thrombolytic Therapy in Clinical Practice The Norwegian Experience
Thrombolytic Therapy in Clinical Practice The Norwegian Experience Thomassen Lars Thomassen, Ulrike Waje-Andreassen, Halvor Næss ABSTRACT Background: Awaiting the European approval of thrombolysis, we
Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center
Brain Attack Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship Stroke is a common and devastating disorder Third leading antecedent of death in American men, and second among
Epidemiology. Epidemiology 6/1/2015. Cerebral Ischemia
Presenter Disclosure Information Paul Nyquist MD/MPH FCCM FAHA Updates on the Acute Care of Ischemic Stroke and Intracranial Hemorrhage Updates on the Acute Care of Ischemic Stroke Paul Nyquist MD/MPH,
NIH Public Access Author Manuscript Am J Ophthalmol. Author manuscript; available in PMC 2011 March 15.
NIH Public Access Author Manuscript Published in final edited form as: Am J Ophthalmol. 2008 November ; 146(5): 631 634. doi:10.1016/j.ajo.2008.07.025. Thrombolysis for Acute Central Retinal Artery Occlusion:
Michael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
Original Article Medical Journal of the Islamic Republic of Iran, Vol. 27, No. 3, Aug 2013, pp. 113-118 Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic
Patients presenting with acute stroke while on DOACs
Patients presenting with acute stroke while on DOACs Vemmos Kostas, MD, PhD Stroke Medicine Hellenic Cardiovascular Research Society Conflicts of interest Honoraria and speaker fees from: BAYER, SANOFI,
Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE
Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE ESUS Progression of haematoma Anticoagulation Large ICH
Acute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center
Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting
Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2
Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2 January 28, 2015 1 to 3 PM Central Time Continuing Education Credit This course
COMPREHENSIVE SUMMARY OF INSTOR REPORTS
COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list
Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature
Romanian Neurosurgery Volume XXXI Number 3 2017 July-September Article Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature Ashish Kumar Dwivedi, Pradeep Kumar,
The principal goal in treating acute ischemic stroke is rapid
ORIGINAL RESEARCH S. Sugiura K. Iwaisako S. Toyota H. Takimoto Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within
Agrowing number of endovascular therapies are available
ORIGINAL RESEARCH N. Zeevi G.A. Kuchel N.S. Lee I. Staff L.D. McCullough Interventional Stroke Therapies in the Elderly: Are We Helping? BACKGROUND AND PURPOSE: It is unclear whether endovascular therapies
MEDICAL POLICY EFFECTIVE DATE: 12/18/08 REVISED DATE: 12/17/09, 03/17/11, 05/19/11, 05/24/12, 05/23/13, 05/22/14
MEDICAL POLICY SUBJECT: CT (COMPUTED TOMOGRAPHY) PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
Update overview 2018 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab
Update overview 2018 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab Introduction Lareb previously published yearly overviews of reports (most recently in 2017) in consultation
Intracranial Hemorrhage in Association With Thrombolytic Therapy: Incidence and Clinical Predictive Factors
JACC Vol. 19, No. 2 289 Intracranial Hemorrhage in Association With Thrombolytic Therapy: Incidence and Clinical Predictive Factors PETER P. DE JAEGERE, MD, ALFRED A. ARNOLD, MD, AGGIE H. BALK, MD, MAARTEN
CASE PRESENTATION. Key Words: cerebral venous thrombosis, internal jugular vein stenosis, thrombolysis, stenting (Kaohsiung J Med Sci 2005;21:527 31)
Treatment of cerebral venous thrombosis SUCCESSFUL TREATMENT OF CEREBRAL VENOUS THROMBOSIS ASSOCIATED WITH BILATERAL INTERNAL JUGULAR VEIN STENOSIS USING DIRECT THROMBOLYSIS AND STENTING: A CASE REPORT
Endovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
La gestione dell ictus ischemico o emorragico nel paziente sotto NAO
La gestione dell ictus ischemico o emorragico nel paziente sotto NAO Antonio Carolei e Cindy Tiseo Clinica Neurologica e Stroke Unit Avezzano - Sulmona Università degli Studi dell Aquila Abano Terme, 10
Stroke is a strongly age-related disease, and the number of
ORIGINAL RESEARCH D. Kim G.A. Ford C.S. Kidwell S. Starkman F. Vinuela G.R. Duckwiler R. Jahan J.L. Saver, for the UCLA Intra- Arterial Thrombolysis Investigators Intra-Arterial Thrombolysis for Acute
Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS
Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner
Thrombolytics and Beyond
Thrombolytics and Beyond Greenville Memorial Rodney Leacock MD Introduction 795,000 strokes per year in the US 87% ischemic 13% hemorrhage, 3% SAH Fourth leading cause of death - was third Mortality rate
Definition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure
Seizures after stroke Can we predict? พ.ญ.ส ธ ดา เย นจ นทร PMK Epilepsy Annual Meeting 2016 Definition Poststroke seizure : single or multiple convulsive episode(s) after stroke and thought to be related
How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage
How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage Rachael Scott, Pharm.D. PGY2 Critical Care Pharmacy Resident Pharmacy Grand Rounds August 21, 2018 2018 MFMER slide-1 Patient
Advances in critical care/emergency medicine 2013
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Advances in critical care/emergency medicine 2013 Keller, Emanuela; Becker,
Advances in Neuro-Endovascular Care for Acute Stroke
Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center
BY MARILYN M. RYMER, MD
Lytics, Devices, and Advanced Imaging The evolving art and science of acute stroke intervention. BY MARILYN M. RYMER, MD In 1996, when the US Food and Drug Administration (FDA) approved the use of intravenous
A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents
Resuscitation (2006) 70, 31 36 CLINICAL PAPER A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents Xin Li a, Qing-ling Fu b, Xiao-li Jing a, Yu-jie
Tyler Carson D.O., Vladamir Cortez D.O., Dan E. Miulli D.O.
Bedside Intracranial Hematoma Evacuation and Intraparenchymal Drain Placement for Spontaneous Intracranial Hematoma Larger than 30 cc in Volume: Institutional Experience and Patient Outcomes Tyler Carson
Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion. An Alternative Option to Intra-arterial Thrombolysis
Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion An Alternative Option to Intra-arterial Thrombolysis Shinichi Nakano, MD; Tsutomu Iseda, MD; Takumi Yoneyama,
Judicious use of thrombolytic agents has greatly improved the
Predictors of Clinical Improvement, Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke J.I. Suarez, MD; J.L. Sunshine, MD; R. Tarr, MD;
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
The management of ICH when to operate when not to?
The management of ICH when to operate when not to? ICH is a Bad Disease High Incidence o Accounts for 10-15% of all strokes 1,2,5 o 80,000 cases in US; 2 million WW 2,5 o Incidence doubles for African-
EFFECT OF OLDER AGE ON THE RISK OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVENOUS AND/OR INTRA-ARTERIAL THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE
EFFECT OF OLDER AGE ON THE RISK OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVENOUS AND/OR INTRA-ARTERIAL THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE By SVETLANA PUNDIK, M.D. Submitted in partial fulfillment of
ACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
Treatment of Acute Ischemic Stroke
NEUROLOGY BOARD REVIEW MANUAL PUBLISHING STAFF PRESIDENT, GROUP PUBLISHER Bruce M. White EDITORIAL DIRECTOR Debra Dreger SENIOR EDITOR Miranda J. Hughes, PhD ASSISTANT EDITOR Rita E. Gould EDITORIAL ASSISTANT
Acute Stroke Treatment: Current Trends 2010
Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment
Protocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
Mechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
CEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
Sinus Venous Thrombosis
Sinus Venous Thrombosis Joseph J Gemmete, MD FACR, FSIR, FAHA Professor Departments of Radiology and Neurosurgery University of Michigan Hospitals Ann Arbor, MI Outline Introduction Medical Treatment Options
Diagnostic and Therapeutic Consequences of Repeat Brain Imaging and Follow-up Vascular Imaging in Stroke Patients
AJNR Am J Neuroradiol 0:7, January 999 Diagnostic and Therapeutic Consequences of Repeat Brain Imaging and Follow-up Vascular Imaging in Stroke Patients Birgit Ertl-Wagner, Tobias Brandt, Christina Seifart,
Rural emergency department best practice for treatment of acute ischemic stroke
Rural emergency department best practice for treatment of acute ischemic stroke Aubrey J. Hoye, DO Ministry Howard Young Medical Center, Woodruff, WI Ministry Eagle River Memorial Hospital, Eagle River,
Myocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
Mechanical thrombectomy with stent retriever in acute ischemic stroke: first results.
Mechanical thrombectomy with stent retriever in acute ischemic stroke: first results. Poster No.: C-0829 Congress: ECR 2014 Type: Scientific Exhibit Authors: M. H. J. Voormolen, T. Van der Zijden, I. Baar,
NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: The Joint Commission Only CMS Voluntary Only
Last Updated: Version 4.4a NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Stroke (STK) Set Measure ID #: Measure Information Form Collected For: The Joint Commission Only CMS
5/15/2018. Reduced Platelet Activity
ASSOCIATION OF DESMOPRESSIN ACETATE ON OUTCOMES IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS ON ANTIPLATELET THERAPY Jessica McManus, Pharm. D. PGY2 Critical Care Pharmacy Resident UF Health Jacksonville
UPSTATE Comprehensive Stroke Center. Neurosurgical Interventions Satish Krishnamurthy MD, MCh
UPSTATE Comprehensive Stroke Center Neurosurgical Interventions Satish Krishnamurthy MD, MCh Regional cerebral blood flow is important Some essential facts Neurons are obligatory glucose users Under anerobic
The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke pilot study
The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke pilot study Jana Dluha a, Stefan Sivak a, Egon Kurca a, Robert Dusenka b, Klaudia Kalmarova a, Monika Turcanova
The prognosis for acute basilar artery occlusion (BAO) is
Published July 17, 2014 as 10.3174/ajnr.A4045 ORIGINAL RESEARCH INTERVENTIONAL Forced Arterial Suction Thrombectomy with the Penumbra Reperfusion Catheter in Acute Basilar Artery Occlusion: A Retrospective
Role of recombinant tissue plasminogen activator in the updated stroke approach
Role of recombinant tissue plasminogen activator in the updated stroke approach Joshua Z. Willey, MD, MS Assistant Professor of Neurology Division of Stroke, Columbia University October 2015 jzw2@columbia.edu
Supplementary Online Content
Supplementary Online Content Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary
Interrater Reliability and Sensitivity of CT Interpretation by Physicians Involved in Acute Stroke Care
Detection of Early CT Signs of >1/3 Middle Cerebral Artery Infarctions Interrater Reliability and Sensitivity of CT Interpretation by Physicians Involved in Acute Stroke Care Mary A. Kalafut, MD; David
Introduction. Overview
Hemorrhagic transformation of ischemic stroke Jorge Moncayo-Gaete MD (Dr. Moncayo-Gaete of the International University of Ecuador has no relevant financial relationships to disclose.) Julien Bogousslavsky
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University
Review Article Differentiating between Hemorrhagic Infarct and Parenchymal Intracerebral Hemorrhage
Hindawi Publishing Corporation Radiology Research and Practice Volume 2012, Article ID 475497, 11 pages doi:10.1155/2012/475497 Review Article Differentiating between Hemorrhagic Infarct and Parenchymal
HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
Emergency Room Procedure The first few hours in hospital...
Emergency Room Procedure The first few hours in hospital... ER 5 level Emergency Severity Index SOP s for Stroke Stroke = Level 2 Target Time = 1 Hour 10 min from door 2 Doctor 25 min from door 2 CT 60
Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and
Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and Interventional Neurology Fellowships University of Louisville School
Volume 13 - Issue 3, Interventions
Volume 13 - Issue 3, 2013 - Interventions Interventional Radiology And Stroke Therapy Authors Dr. Leo Lawler Dr. Matt Crockett Dr. Eoin Kavanagh Prof. Sean Murphy Stroke Physician Mater Misericordiae University
Emergency Department Management of Acute Ischemic Stroke
Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,
Embolization of a Chronic Left Ventricular Thrombus Following Thrombolytic Treatment for Acute Myocardial Infarction
Case Report Embolization of a Chronic Left Ventricular Thrombus Following Thrombolytic Treatment for Acute Myocardial Infarction Robert N. DiTrolio, DO, FACOI Robert F. Sing, DO, FACEP, FACSM Domenic Pisano,
Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University
Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without
IDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS. Ettore Beghi Istituto Mario Negri, Milano ITALY
IDENTIFYING TARGET POPULATIONS & DESIGNING CLINICAL TRIALS FOR ANTIEPILEPTOGENESIS Ettore Beghi Istituto Mario Negri, Milano ITALY OUTLINE Definitions & background risks in epilepsy End-points Target populations